Cromolyn Sodium
NDC 17478-291
Product Information
Cromolyn Sodium is a ANDA-approved product labeled by Akorn. This medication is used to treat certain allergic eye conditions (vernal keratoconjunctivitis, vernal conjunctivitis, vernal keratitis). It is supplied as a product. This product entry covers the primary NDC 17478-291 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 17478-291?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CROMOLYN SODIUM (UNII: Q2WXR1I0PK)
- CROMOLYN (UNII: Y0TK0FS77W) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- WATER (UNII: 059QF0KO0R)
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 831109 - cromolyn sodium 4 % Ophthalmic Solution
- RxCUI: 831109 - cromolyn sodium 40 MG/ML Ophthalmic Solution
* Please review the full disclaimer at the bottom of this page.
Patient Education
Cromolyn Ophthalmic
Cromolyn ophthalmic is used to treat the symptoms of allergic conjunctivitis (a condition in which the eyes become itchy, swollen, red, and teary when they are exposed to certain substances) and keratitis (a condition that causes swelling of the cornea [tissue in the front of the eye] that causes eye redness, pain, and tearing and changes in vision) in adults and children 4 years of age and older. Cromolyn is in a class of medications called mast cell stabilizers. It works by preventing the release of substances that cause inflammation (swelling) of the eyes.
[Learn More]
* Please review the full disclaimer at the bottom of this page.